Zobrazeno 1 - 10
of 567
pro vyhledávání: '"Pneumovirinae"'
Autor:
Russell CJ; 1 Department of Infectious Diseases, St. Jude Children's Research Hospital , Memphis, Tennessee.; 2 Department of Molecular Biology, Immunology, and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee., Simões EAF; 3 Department of Pediatrics, University of Colorado School of Medicine, Department of Epidemiology, Colorado School of Public Health, Section of Infectious Diseases, Children's Hospital Colorado, Aurora, Colorado., Hurwitz JL; 1 Department of Infectious Diseases, St. Jude Children's Research Hospital , Memphis, Tennessee.; 2 Department of Molecular Biology, Immunology, and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee.
Publikováno v:
Viral immunology [Viral Immunol] 2018 Mar; Vol. 31 (2), pp. 133-141. Date of Electronic Publication: 2018 Jan 11.
Autor:
Byrne PO; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: jmclellan@austin.utexas.edu.
Publikováno v:
Current opinion in immunology [Curr Opin Immunol] 2022 Aug; Vol. 77, pp. 102209. Date of Electronic Publication: 2022 May 19.
Autor:
Lo MK; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Jordan R; Gilead Sciences, Inc. Foster City, California, USA., Arvey A; Gilead Sciences, Inc. Foster City, California, USA., Sudhamsu J; Gilead Sciences, Inc. Foster City, California, USA., Shrivastava-Ranjan P; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Hotard AL; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Flint M; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McMullan LK; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Siegel D; Gilead Sciences, Inc. Foster City, California, USA., Clarke MO; Gilead Sciences, Inc. Foster City, California, USA., Mackman RL; Gilead Sciences, Inc. Foster City, California, USA., Hui HC; Gilead Sciences, Inc. Foster City, California, USA., Perron M; Gilead Sciences, Inc. Foster City, California, USA., Ray AS; Gilead Sciences, Inc. Foster City, California, USA., Cihlar T; Gilead Sciences, Inc. Foster City, California, USA., Nichol ST; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Spiropoulou CF; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Publikováno v:
Scientific reports [Sci Rep] 2017 Mar 06; Vol. 7, pp. 43395. Date of Electronic Publication: 2017 Mar 06.
Autor:
Melero JA; Centro Nacional de Microbiología and CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain. Electronic address: jmelero@isciii.es., Mas V; Centro Nacional de Microbiología and CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain.
Publikováno v:
Virus research [Virus Res] 2015 Nov 02; Vol. 209, pp. 128-35. Date of Electronic Publication: 2015 Mar 01.
Autor:
Blanco J; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Edificio Departamental Lab.106. Plaza Doctores de la Reina s/n, 37007, Salamanca, Spain., Cameirao C; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Edificio Departamental Lab.106. Plaza Doctores de la Reina s/n, 37007, Salamanca, Spain.; Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253, Bragança, Portugal., López MC; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Edificio Departamental Lab.106. Plaza Doctores de la Reina s/n, 37007, Salamanca, Spain., Muñoz-Barroso I; Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Edificio Departamental Lab.106. Plaza Doctores de la Reina s/n, 37007, Salamanca, Spain. imunbar@usal.es.
Publikováno v:
Archives of virology [Arch Virol] 2020 Oct; Vol. 165 (10), pp. 2165-2176. Date of Electronic Publication: 2020 Aug 01.
Autor:
Petraityte R; Institute of Biotechnology, V. Graiciuno 8, Vilnius, Lithuania. prasa@ibt.lt, Tamosiunas PL, Juozapaitis M, Zvirbliene A, Sasnauskas K, Shiell B, Russell G, Bingham J, Michalski WP
Publikováno v:
Virus research [Virus Res] 2009 Oct; Vol. 145 (1), pp. 92-6. Date of Electronic Publication: 2009 Jun 25.
Publikováno v:
Clinical microbiology reviews [Clin Microbiol Rev] 2004 Apr; Vol. 17 (2), pp. 390-412.
Autor:
Tong S; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. sot1@cdc.gov, Chern SW, Li Y, Pallansch MA, Anderson LJ
Publikováno v:
Journal of clinical microbiology [J Clin Microbiol] 2008 Aug; Vol. 46 (8), pp. 2652-8. Date of Electronic Publication: 2008 Jun 25.
Autor:
van den Hoogen BG; Department of Virology, Erasmus Medical Center Rotterdam, Dr. Molewaterplein 50, Rotterdam, 3015 GE, The Netherlands., Bestebroer TM, Osterhaus AD, Fouchier RA
Publikováno v:
Virology [Virology] 2002 Mar 30; Vol. 295 (1), pp. 119-32.
Autor:
Smith SE; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.; Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom., Busse DC; Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St. Mary's Campus, London, United Kingdom., Binter S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.; Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom., Weston S; MRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom., Diaz Soria C; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom., Laksono BM; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands., Clare S; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom., Van Nieuwkoop S; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands., Van den Hoogen BG; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands., Clement M; Division of Infection and Immunity/Systems Immunity University Research Institute, Cardiff University, Cardiff, United Kingdom., Marsden M; Division of Infection and Immunity/Systems Immunity University Research Institute, Cardiff University, Cardiff, United Kingdom., Humphreys IR; Division of Infection and Immunity/Systems Immunity University Research Institute, Cardiff University, Cardiff, United Kingdom., Marsh M; MRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom., de Swart RL; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands., Wash RS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom.; Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom., Tregoning JS; Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St. Mary's Campus, London, United Kingdom john.tregoning@imperial.ac.uk paul.kellam@imperial.ac.uk., Kellam P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom john.tregoning@imperial.ac.uk paul.kellam@imperial.ac.uk.; Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St. Mary's Campus, London, United Kingdom.; Kymab Ltd., Babraham Research Campus, Cambridge, United Kingdom.
Publikováno v:
Journal of virology [J Virol] 2019 Mar 05; Vol. 93 (6). Date of Electronic Publication: 2019 Mar 05 (Print Publication: 2019).